Skip to main content

Table 1.

Baseline patients characteristics

Group A (n=56) Group B (n=47) p
Age (years) MV±SD 62±7 59±9 0.134
Male gender N (%) 49(88) 41(87) 0.968
Smoking history N (%) 50(89) 44 (94) 0.438
Co-morbidities N (%) 50(89) 34(72) 0.027
Hypertension N (%) 28(50) 18(38) 0.234
Coronary disease N (%) 11(20) 9(19) 0.950
Heart failure N (%) 4(7) 1(2) 0.238
Diabetes mellitus N (%) 7(13) 4(8) 0.514
Chronic renal failure N (%) 0(0) 2(4) 0.119
COPD stage: I/II/III/IV N (%) 10(18)/ 39(69)/ 6(11)/ 1(2) 24(51)/ 22(47)/ 1(2)/ 0(0) 0.002
Basal spirometry:
FEV1 (mL) MV±SD 1948±569 2509±741 <0.001
FEV1% pred. MV±SD 65±14 79±18 <0.001
VC (mL) MV±SD 3352±873 3731±1088 0.055
VC% pred. MV±SD 88±15 94±21 0.116
Tiffneau index % MV±SD 56±8 62±6 <0.001
FEF50% MV±SD 29±14 44±24 <0.001
IC% MV±SD 74±11 84±12 <0.01
FEF25% MV±SD 27±18 42±24 0.001
Pulmonary resection:
Pneumonectomy N (%) 13(23) 5(11) 0.094
Lobectomy N (%) 43(77) 42(89) 0.094
Total hospital stay (days) MV±SD 36±19 25±12 <0.001
Preop.hospital stay (days) MV±SD 21±12 9±6 <0.001
Postop.hospital stay (days) MV±SD 16±9 16±8 0.571
Total complications N (%) 20(36) 21(45) 0.354
Pulmonary complications N (%) 17(30) 20(43) 0.199
In-hospital mortality N (%) 2(4) 0(0) 0.191

COPD = chronic obstructive pulmonary disease.